Correlation Between JPMorgan Chase and NOVARTIS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both JPMorgan Chase and NOVARTIS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining JPMorgan Chase and NOVARTIS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between JPMorgan Chase Co and NOVARTIS CAPITAL P, you can compare the effects of market volatilities on JPMorgan Chase and NOVARTIS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in JPMorgan Chase with a short position of NOVARTIS. Check out your portfolio center. Please also check ongoing floating volatility patterns of JPMorgan Chase and NOVARTIS.

Diversification Opportunities for JPMorgan Chase and NOVARTIS

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between JPMorgan and NOVARTIS is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding JPMorgan Chase Co and NOVARTIS CAPITAL P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NOVARTIS CAPITAL P and JPMorgan Chase is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on JPMorgan Chase Co are associated (or correlated) with NOVARTIS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NOVARTIS CAPITAL P has no effect on the direction of JPMorgan Chase i.e., JPMorgan Chase and NOVARTIS go up and down completely randomly.

Pair Corralation between JPMorgan Chase and NOVARTIS

Considering the 90-day investment horizon JPMorgan Chase Co is expected to under-perform the NOVARTIS. But the stock apears to be less risky and, when comparing its historical volatility, JPMorgan Chase Co is 2.73 times less risky than NOVARTIS. The stock trades about -0.15 of its potential returns per unit of risk. The NOVARTIS CAPITAL P is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  6,511  in NOVARTIS CAPITAL P on September 18, 2024 and sell it today you would earn a total of  380.00  from holding NOVARTIS CAPITAL P or generate 5.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy90.48%
ValuesDaily Returns

JPMorgan Chase Co  vs.  NOVARTIS CAPITAL P

 Performance 
       Timeline  
JPMorgan Chase 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in JPMorgan Chase Co are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, JPMorgan Chase displayed solid returns over the last few months and may actually be approaching a breakup point.
NOVARTIS CAPITAL P 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NOVARTIS CAPITAL P has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, NOVARTIS is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

JPMorgan Chase and NOVARTIS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with JPMorgan Chase and NOVARTIS

The main advantage of trading using opposite JPMorgan Chase and NOVARTIS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if JPMorgan Chase position performs unexpectedly, NOVARTIS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NOVARTIS will offset losses from the drop in NOVARTIS's long position.
The idea behind JPMorgan Chase Co and NOVARTIS CAPITAL P pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
FinTech Suite
Use AI to screen and filter profitable investment opportunities